Ganga Pharmaceuticals Ltd.
| BSE: 539680 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE615T01017 |
| BSE 00:00 | 22 Sep | 5.00 |
0 (0.00%) |
OPEN
5.00 |
HIGH
5.00 |
LOW
5.00 |
| NSE 05:30 | 01 Jan | Ganga Pharmaceuticals Ltd |
| OPEN | 5.00 |
| PREVIOUS CLOSE | 5.00 |
| VOLUME | 8000 |
| 52-Week high | 10.80 |
| 52-Week low | 5.00 |
| P/E | 100.00 |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Ganga Pharmaceuticals Ltd. (GANGAPHARMA) - Announcements
-
Ganga Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
04/09/2021 | bse
-
Ganga Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
04/09/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM
04/09/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Reg. 34 (1) Annual Report
10/08/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd 32Nd Annual General Meeting Of The Company On Saturday September 04 2021
10/08/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Notice Of Book Closure And Annual General Meeting
04/08/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On 04Th August 2021
04/08/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Regulation 23(9) - Disclosure Of Related Party Transactions On Consolidation Basis
27/07/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Shareholding for the Period Ended June 30 2021
08/07/2021 | bse
-
Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/07/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended June 2021
08/07/2021 | bse
-
Ganga Pharmaceuticals Ltd Outcome Of The Board Meeting Held Today I.E. On June 28 2021<BR>
28/06/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Outcome Of The Board Meeting Held Today I.E. On June 28 2021
28/06/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Board Meeting Intimation for Considering And Approving The Audited (Standalone) Financial Results Of
17/06/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Compliance Certificate Under Regulation 7(3) Of LODR For The Half Year Ended March 31 2021
30/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
29/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation 2015 For The Half Year Ended
26/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
26/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
14/04/2021 | bse
-
Ganga Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2021
12/04/2021 | bse
Quick Links for Ganga Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
